Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
May 8, 2013 terifay robert j Officer Sell 8,231 260.86 - 262.06
May 6, 2013 van plew daniel p Officer Disposition (Non Open Market) 15,323 260.44
Dec 12, 2013 yancopoulos george Officer Option Execute 9,599 260.44
May 6, 2013 yancopoulos george Officer Disposition (Non Open Market) 103,243 260.44
May 6, 2013 gilman alfred g Director Sell 30,000 260.41 - 264.82
May 6, 2013 tessier-lavigne marc Director Sell 13,334 260.20 - 264.17
May 6, 2013 shooter eric m Director Sell 10,000 258.78 - 264.18
May 6, 2013 shooter eric m Director Sell 20,000 256.49 - 264.13
May 6, 2013 aberman michael s Officer Sell 8,334 256.46 - 257.29
May 21, 2013 goldberg murray a Officer Automatic Sell 66,835 255.52 - 264.61
May 28, 2013 goldstein joseph l Director Sell 4,000 252.20
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
May 2, 2013 mccorkle douglas s Officer Automatic Sell 2,213 241.45 - 247.21
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
May 1, 2013 mccorkle douglas s Officer Automatic Sell 3,662 233.53
May 1, 2013 schleifer leonard s Officer Automatic Sell 100,000 225.01 - 250.06
Apr 12, 2013 mccorkle douglas s Officer Automatic Sell 3,129 205.82 - 214.10
Showing 121-140 of 822 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)